Anagrafe della ricerca

HyMedPoly - Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications

49 mesi (2015 - 2018)
Responsabile scientifico:
Tipo di progetto:
Ricerca UE - H2020 - Excellent Science - Marie Curie
Ente finanziatore:
Codice identificativo progetto:


There is a general consensus that biomedical polymers of natural and synthetic origin should and will play a very important role in the development of new therapeutic strategies to treat diseases. Due to resistance of bacteria to drugs, infection has become one of the toughest problems in the medical world as there are hardly any effective antibiotics left in the fight against many pathogens. This project aims to develop new therapies through a new combination of technology (a) development of new hybrid polymers with antibacterial functionality,(b) introduction of inhibitors that can permanently deactivate bacteriological proteases and (c) new formulations of bioactive ceramics and glasses that have specific charge potential to prevent bacterial growth. The challenge is to develop new medical polymers that have an intrinsic antibacterial functionality to achieve clinical effectiveness in the field

Persone coinvolte

Dipartimenti coinvolti




Costo totale progetto: € 3.918.054,96
Contributo totale progetto: € 3.918.054,96
Costo totale PoliTo: € 1.032.245,28
Contributo PoliTo: € 722.091,80